Manufacture

Enzyme engineering has opened up new possibilities in biocatalysis, but computational techniques and smart libraries also make wildtypes feasible. The choice is yours.

Why we shouldn’t forget gelatin’s longstanding reputation as a reliable and trusted excipient.

Gene encounters some challenges with chromatographic performance.

A robotic arm takes mass spec analysis of 3D objects to the next level.

Rick Morris shares lessons learned based on a career of polymers and building biopharma equipment.

Meet Bristol-Myers Squibb’s Bryan (Bo) Barnhart, who is a passionate advocate for the immuno-oncology field.

China is upping its game with plans to revolutionize its manufacturing industries, including pharma.

Catalysis is increasingly being adopted by pharma because it can bring down costs.

Drug emissions in UK rivers raise questions about long-term consequences for the environment.

No dinosaurs were harmed in the making of this vaccine…